InvestorsHub Logo
Followers 124
Posts 3033
Boards Moderated 1
Alias Born 08/11/2022

Re: None

Saturday, 05/11/2024 5:30:45 PM

Saturday, May 11, 2024 5:30:45 PM

Post# of 1722
What if TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and other get partnership agreement with a giant Pharma
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RNAZ News